In the course of improving the pradimicin producing strain, we have generated four mutants blocked in pradimicin biosynthesis. The mutants produced 5,6-dihydrobenzo[a]naphthacenequinone metabolites designated pradimicins N (6), P (7), O (8) and M (9). In this report, we describe the isolation of the producing mutants and isolation, physico-chemical properties and structural determination of the four new metabolites.
Several biologically active dihydrobenzo [a]naphthacenequinone derivatives have recently been isolated from various microorganisms. The potent antifungal antibiotics pradimicins A (1) and C (2) were isolated from the culture filtrate ofActinomadura hibisca P1 57-2 (ATCC53557)1~4). Pradimicinone (4), the aglycone of pradimicins and its dealanyl derivative (5) were obtained by acid hydrolysis of pradimicins A and C. In addition, benanomicins A (3) and B5), SF24466), KS-619-17), G-2A and G-2N8) all possess the 5,6-dihydrobenzo [a]naphthacenequinone nucleus.
In the course of improving the pradimicin producing strain, we have generated four mutants blocked in pradimicin biosynthesis. The mutants produced 5,6-dihydrobenzo[a]naphthacenequinone metabolites designated pradimicins N (6), P (7), O (8) and M (9) . In this report, we describe the isolation of the producing mutants and isolation, physico-chemical properties and structural determination of the four new metabolites.
Materials and Methods

Strain Maintenance
A. hibisca PI57-2 and its mutant strains were grown on a solid medium which contained soluble starch 0.5%, glucose 0.5%, fish meat extract 0.1%, yeast extract 0.1%, NZ-case 0.2%, NaCl 0.2%, CaCO3 0.1% and agar 1.6%, pH 7.2, and were maintained at 4°C.
Isolation of Mutants
JV-Methyl-Af'-nitro-N-nitrosoguanidine (MNNG) was used as a mutagen with strain PI 57-2 as described in the previous paper9).
Each mutant was transferred from the solid mediuminto a vegetative medium(medium A: 10ml in 50-ml Erlenmeyer flask) consisting of glucose 3%, soybean meal 3%, Pharmamedia 0.5%, yeast extract 0.1% and CaCO30.3%, pH 7.0, and cultivated at 28°C for 7 days at 200rpm on a rotary shaker.
First, antifungal activity of the whole fermentation broths against Cryptococcus neoformans IAM 4514 inoculated in Sabouraud dextrose agar (Neopeptone 1%, glucose 2%, and agar 1.5%, pH 9.0) was determined. The broth was diluted by serial 2-fold dilution. The sample (80 u\) was put into a well (8mm i.d.) in the agar mediumand incubated at 37°C for 2 days. The diameter of the inhibitory zone was measured and broths with weaker activity than the parent strain were selected. Next, we looked for new products in these selected broths using silica gel TLC. The broth was extracted with an equal volume of butanol at pH about 2.0. The butanol extract (20/il) was loaded on a silica gel plate (60F254, 0.25mm thick, E. Merck) and developed with methyl acetate -1-propanol -28% ammonia (9 : 21 : 12). New products were identified based on the color and Rf value as compared to the known components on the plate. Rf values: 0.47 for pradimicin M, 0.46 for pradimicin O, 0.44 for pradimicin N, 0.22 for pradimicin P, 0.28 for pradimicin A, 0.42 for pradimicin B and 0.23 for pradimicin C. An agar plug of the mutant was transferred into 100ml of medium A in a 500-ml Erlenmeyer flask and cultivated at 28°C for 6 days at 200rpm. This culture (5ml) was transferred into 500-ml flasks containing 100ml of fresh medium A. The fermentation was carried out at 28°C for 7 days.
Isolation of NewMetabolites
The fermentation broth of strain A1077 (1.5 liters) was centrifuged at 5,000rpm for 10minutes at room temperature. The supernate was adjusted to pH 2.0 with 3n HC1and mixed with an equal volume of ethyl acetate. The ethyl acetate layer was separated and extracted with an equal volume of water at pH 8.5 (adjusted with 3 n NaOH). The aqueous layer was adjusted to pH 2.0 and extracted with a half volume of ethyl acetate. The ethyl acetate layer was concentrated in vacuo to give 5.0g of crude solid. The solid was subjected to silica gel column chromatography (Wakogel C-200, column size: i.d. 3 x 80cm) eluted with a linear gradient of methylene chloride-methyl acetate (9 : 1 to 1 : 1). The eluted fractions (10ml) were tested by silica gel TLCas described above. The fractions containing the desired product were pooled, concentrated to dryness and then applied to a reversed-phase silica gel column (ODS-A60, Yamamura Chemical Lab., column size: i.d. 2.5 x50cm) which was developed with acetonitrile-0.15% (ll mM) KH2PO4 buffer, pH 3.5 (1 : 1). The eluate was analyzed by HPLC (Waters M600, YMCA-301-3, ODS, i.d. 4 .6mm x 100mm, 3^m, Yamamura Chemical Lab.) eluted with acetonitrile -0.15% KH2PO4buffer, pH 3.5 (3 : 7) and detected at 254 nm. The fractions containing a single product were pooled and concentrated to dryness. The residue was dissolved in a mixture of methanol-water (1 : 1, pH 8.0) and passed through a column of Sephadex LH-20eluted with the same solvent mixture. The fractions containing single products were concentrated to dryness, redissolved in acetonitrile, and 0.1 n hydrochloric acid was added. The resulting red precipitate was filtered, washed once with chilled water and dried in vacuo, yielding 30mg ofpradimicin N. By a similar procedure, 1 34 mg ofpradimicin P (strain C2248, 480 ml), 40 mg ofpradimicin M(strain B2162, 9 liters) and 18mg of pradimicin O (strain C2099, 4 liters) were obtained.
General
UVand IR spectra were recorded on a Shimadzu UV-260spectrophotometer and an Analect JIR-fx6160 FT spectrophotometer, respectively. FAB-MSwere obtained on a Jeol JMS-AX505Hwith a 5 KeVbeam of energetic xenon atoms and 3 KVas an acceleration voltage using raeta-nitrobenzyl alcohol as a matrix. HRFAB-MS spectra were obtained by the same equipment using double target probe and polyethylene glycol 600 as an external mass standard. *H and 13C NMRspectra were recorded on Jeol JNM-GX400spectrometer with DMSO-J6as an internal standard. 13C NMRspectra were obtained by measuring the samples prepared at pH 2 in DMSO-<4at 60°C.
Results
Isolation of Mutants
Three sets of MNNG mutation experiments were carried out starting from A. hibisca PI57-2, the parent pradimicin-producing strain ( Table 1 ). The blocked mutant A1077 produced pradimicin N as the dominant metabolite.
In the first set of experiments, strain A1017 was also isolated as the pradimicin A producer. As this strain showed favorably abundant and uniform spores upon growth, it was subjected to the next set of experiments. Two blocked mutants C2099 and C2248 were isolated from the mutation of strain A1017.
The former co-produced pradimicins A and O, while the latter yielded pradimicins A and P. Mutant B2162 was isolated from the third set of mutations of strain A1077, and found to co-produce NOV. 1990 pradimicins Mand N. Morphological observations and cultural characteristics of the four blocked mutants were almost identical with those of the parent strain PI57-2 (data not shown).
Fermentation and Isolation Production of the newmetabolites was achieved on the flask fermentation scale. The metabolites were purified by silica gel and reversed-phase silica gel column chromatographies to analytically pure material. All the new metabolites showed no anticandidal activity at 100 /ig/ml in Sabouraud dextrose agar medium (pH7.0).
Physico-chemical Properties
Physico-chemical properties of the compounds 6, 7, 8 and 9 are summarized in Table 2 in comparison with 4 and 51'2*. The molecular formulae of6, 7, 8 and 9 were determined by HRFAB-MSas C29H25NO12, C27H2iNO12, C29H25NO!! and C24H16O10, respectively. The UVspectra of6 and 8 are similar to those of 1, 2, 4, and 5, indicating that they have similar hydroxyl substitutions on the anthracenequinone core.
The visible absorption spectra of 7 and 9 in alkaline mediumshoweda morepronounced bathochromic shift than those of 6 and 8, suggesting a polyhydroxyanthraquinone structure such as G-2A, G-2N8). In the IR spectra of these compounds, strong absorptions were obtained around 1622~1603cm"1 due to the C=O stretching of the hydrogen-bonded quinone carbonyl groups with the peri hydroxyl10). The absorption band at around 1720cm"1 in 6~8 was assigned to a carboxyl group since it disappeared in the spectra of their sodium salts. An amido carbonyl band at around 1660cm"1 was detected in 4, 6, 7 and 8, but not in 5 and 9. In the FAB-MS, 4, 6, 7 and 8 displayed a characteristic (M-88)+ fragment ion due to the cleavage of alanine.
Structure Elucidation
The structures of the newly isolated pradimicins 6~9 were determined on the basis of *H and 13C NMRspectral analyses (Tables 3 and 4 ). The complete NMRassignment of pradimicinone (4) has been carried out previously using 2D NMR2)and biosynthetic experiments11\ Whenthe NMRspectrum of 6 was compared to that of 4, one singlet aromatic proton signal at 3 8.ll (7-H) of 4 was missing, whereas an additional methoxy methyl signal was found at 3 3.90. The O-methyl proton exhibited a correlation peak to 6-H (3 5.03) in the 2D homonuclear NOE(NOESY)experiment. In the long range XH-13C COSY spectrum of 6, the O-methyl proton (3 3.90) coupled with the new quarternary carbon at 3 153.7 (3«/Ch)> which also coupled with the methine proton at 6-H (3 5.03). These results indicated that 6 was the 7-methoxy analogof4.
The *H NMRspectra of 7 closely resembled 6 except for the absence of two methoxy methyl signals observed in 6. In the NOESYexperiment, two hydroxy protons at 3 12.18 and 12.76 showed cross peaks with 12-H (3 7.29) and 6-H (3 5.10), respectively. Therefore, the structure of 7 was determined to be 7,1 1-O-demethyl analog of 6.
The *H and 13C NMRspectra of8 showed that 8 differed from 6 only at the C-6 position. A methine carbon signal at 3 63.8 in the 13C NMRspectrum of 6 appeared as a methylene carbon signal at 3 31.5 in that of 8. The 3/HH coupling constants between C-5 methine and C-6 methylene of 8 were 9.4 and 3.9Hz, and NOE's of 5-H to 4-H and of 6-H to C-7 methoxy were observed.
Furthermore, the pseudomolecular ion (M+H)+of 8 in FAB-MSspectrum was 16 mass units lower than that of 6. From Table 3 . *H NMRchemical shifts ofpradimicins N, P, O and M. NOV. 1990 Pradimicin N (6) Pradimicin P Pradimicin O Pradimicin M Multiplicity and coupling constants (Hz) are in parentheses. Table 4 . 13C NMRchemical shifts of pradimicinone, dealanyl pradimicinone, pradimicins N, P, O and M.
Pradimicin N Pradimicin P Pradimicin O Pradimicin M (6) ( 7) (8) these results 8 was determined to be the 6-deoxy-derivative of compound 6. Upon acid hydrolysis, 6, 7 and 8 gave alanine together with the corresponding aglycones. The alanine was determined to have the D-configuration based on HPLCanalysis as previously reported2). Pradimicin M (9) showed the molecular formula of C24H16O10 by HRFAB-MSwhich was 14 mass units smaller than that of5. In the *H NMRspectrum of9, a meta-coupling (J=2.6 Hz) between aromatic protons 10-H and 12-H and a vicinal coupling (.7=3.4Hz) between 5-H/6-H were observed along with three NOEsbetween methyl on C-3/4-H, 4-H/5-H and 6-H/7-H, demonstrating the same substitution as 5. However, the lack of an 0-methyl signal in 9 suggested that the C-ll methoxy group in 5 was replaced by a hydroxy group in 9. The 1H-13C correlation of 9 was obtained based on the long range 1H-13C COSYspectra (Fig..2) . Twoaromatic protons 7-H and 12-H at the peri position of the quinones coupled to quinone carbonyl carbon at S 189.0 (C-8) and 181.0 (C-13), respectively. Furthermore, a weak W-type coupling was observed between 7-H and C-13. The C-8 quinone carbonyl carbon resonated at an 8ppm lower field than C-13, which in turn displayed a diamagnetic shift of approximately 6 ppm compared with the C-13 of 5. The benzylic proton 5-H coupled to two aromatic carbons C-6a (37CH=5.1 Hz) and C-14b (3;CH=4.4Hz), and 6-H was coupled to four carbons C-6a, C-4a (3/CH=4.4Hz), C-14a (3/CH=3.7Hz) and C-14 by a W-type coupling. From these data, the structure of 9 is ll-O-demethyl-5 with a different stereochemistry at C-5 and C-6 from that of 5. In all the new pradimicin components, the magnitude of vicinal coupling constants between 5-H and 6-H was around.7=3.4Hz (and.7=9.4Hz in case of 8) which distinctly differed from those of pradimicin A and compounds 4 and 5 (.7= 10.7Hz). Therefore, the conformations at C-5 and C-6 of these new components are different from those of the original pradimicins. The determination of the stereochemistry will be the topic of future publication.
Discussion
The biosynthesis of 5,6-dihydrobenzo[a]naphthacenequinone nucleus in pradimicins and benanomicins was reported by two independent groups11>12) where 13C-acetate-labeled antibiotics were analyzed by 13C NMR. There have been no reports on the isolation of mutants specifically blocked in their biosynthetic pathways. Pradimicin P (7) was found as a major product in the fermentation of strain C2248, but was originally isolated as a minor by-product of the parent strain PI57-2 (unpublished result). Pradimicin M (9) was isolated from the fermentation broth of a mutant B2162 which was derived from pradimicin N-producing mutant A1077 by MNNG mutation. From the structure of 9, it is probable that 9 may be an early intermediate of pradimicin biosynthesis. As expected, all new metabolites were devoid of antifungal activity. No glycosidated compoundsof the above characterized new aglycones have so far been isolated from fermentation broths of the mutants. However, it will be intriguing to see if glycosidated compounds with different conformations at C-5 and C-6 from those of the pradimicins have antifungal, antiviral, antibacterial, or antitumor activity.
While this publication was being written, a new a-glucosidase inhibitor, benanomicin C was published13). Although a direct comparison has not been carried out, benanomicin C is considered to be identical with pradimicin N from the reported data.
